ALAN H AUERBACH Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ALAN H AUERBACH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ALAN H AUERBACH. ALAN H AUERBACH is President and CEO in Cougar Biotechnology, Inc. ($CGRB) and PRESIDENT AND CEO in PUMA BIOTECHNOLOGY, INC. ($PBYI) and Director in Radius Health, Inc. ($RDUS).
Latest Insider Trading Transactions of ALAN H AUERBACH
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CGRB, PBYI, RDUS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 05 2021 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 9.01 | 1,758 | 15,847 | 4,428,407 | 4.4 M to 4.4 M (-0.04 %) |
| Apr 06 2021 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 9.80 | 1,584 | 15,528 | 4,430,165 | 4.4 M to 4.4 M (-0.04 %) |
| Mar 04 2021 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 10.14 | 1,238 | 12,556 | 4,431,749 | 4.4 M to 4.4 M (-0.03 %) |
| Feb 19 2021 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Option Exercise | A | 12.02 | 210,944 | 2,535,547 | 210,944 | |
| Feb 19 2021 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Grant | A | 0.00 | 149,951 | 0 | 4,432,987 | 4.3 M to 4.4 M (+3.50 %) |
| Feb 04 2021 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 12.22 | 1,222 | 14,931 | 4,283,036 | 4.3 M to 4.3 M (-0.03 %) |
| Jan 06 2021 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 10.22 | 18,235 | 186,380 | 4,284,258 | 4.3 M to 4.3 M (-0.42 %) |
| Dec 04 2020 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 11.66 | 355 | 4,138 | 4,302,493 | 4.3 M to 4.3 M (-0.01 %) |
| Oct 05 2020 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 10.13 | 350 | 3,545 | 4,303,219 | 4.3 M to 4.3 M (-0.01 %) |
| Sep 03 2020 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 9.78 | 347 | 3,393 | 4,303,569 | 4.3 M to 4.3 M (-0.01 %) |
| Aug 05 2020 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 10.79 | 330 | 3,561 | 4,303,916 | 4.3 M to 4.3 M (-0.01 %) |
| Jul 06 2020 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 10.66 | 2,607 | 27,803 | 4,304,246 | 4.3 M to 4.3 M (-0.06 %) |
| Jun 04 2020 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 10.71 | 242 | 2,592 | 4,306,853 | 4.3 M to 4.3 M (-0.01 %) |
| Jun 04 2020 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 10.70 | 100 | 1,070 | 4,307,095 | 4.3 M to 4.3 M (0.00 %) |
| May 06 2020 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 9.70 | 339 | 3,289 | 4,307,195 | 4.3 M to 4.3 M (-0.01 %) |
| May 06 2020 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 9.70 | 339 | 3,289 | 4,307,195 | 4.3 M to 4.3 M (-0.01 %) |
| Apr 03 2020 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 7.39 | 347 | 2,563 | 4,307,534 | 4.3 M to 4.3 M (-0.01 %) |
| Mar 03 2020 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 10.02 | 372 | 3,726 | 4,307,881 | 4.3 M to 4.3 M (-0.01 %) |
| Feb 13 2020 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Option Exercise | A | 12.34 | 161,649 | 1,994,749 | 161,649 | |
| Feb 13 2020 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Grant | A | 0.00 | 127,553 | 0 | 4,308,253 | 4.2 M to 4.3 M (+3.05 %) |
| Feb 04 2020 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 8.01 | 331 | 2,653 | 4,180,700 | 4.2 M to 4.2 M (-0.01 %) |
| Jan 03 2020 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 8.39 | 5,973 | 50,113 | 4,181,031 | 4.2 M to 4.2 M (-0.14 %) |
| Jan 03 2020 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 8.39 | 5,973 | 50,113 | 4,181,031 | 4.2 M to 4.2 M (-0.14 %) |
| Jan 03 2020 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 8.32 | 43 | 358 | 4,187,004 | 4.2 M to 4.2 M (0.00 %) |
| Jan 03 2020 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 8.32 | 43 | 358 | 4,187,004 | 4.2 M to 4.2 M (0.00 %) |
| Dec 03 2019 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 10.33 | 455 | 4,700 | 4,187,047 | 4.2 M to 4.2 M (-0.01 %) |
| Dec 03 2019 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 10.33 | 455 | 4,700 | 4,187,047 | 4.2 M to 4.2 M (-0.01 %) |
| Dec 03 2019 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 10.33 | 455 | 4,700 | 4,187,047 | 4.2 M to 4.2 M (-0.01 %) |
| Nov 05 2019 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 7.40 | 100 | 740 | 4,187,502 | 4.2 M to 4.2 M (0.00 %) |
| Nov 05 2019 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 7.40 | 378 | 2,797 | 4,187,602 | 4.2 M to 4.2 M (-0.01 %) |
| Oct 03 2019 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 9.97 | 504 | 5,027 | 4,187,980 | 4.2 M to 4.2 M (-0.01 %) |
| Sep 06 2019 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 10.14 | 524 | 5,313 | 4,188,484 | 4.2 M to 4.2 M (-0.01 %) |
| Aug 05 2019 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 9.01 | 1 | 9 | 4,189,008 | 4.2 M to 4.2 M (0.00 %) |
| Aug 05 2019 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 9.03 | 516 | 4,659 | 4,189,009 | 4.2 M to 4.2 M (-0.01 %) |
| Jul 24 2019 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 9.98 | 12,715 | 126,846 | 4,189,525 | 4.2 M to 4.2 M (-0.30 %) |
| Jul 03 2019 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 12.78 | 495 | 6,326 | 4,202,240 | 4.2 M to 4.2 M (-0.01 %) |
| Jun 05 2019 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 15.18 | 483 | 7,332 | 4,202,735 | 4.2 M to 4.2 M (-0.01 %) |
| May 06 2019 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 32.38 | 477 | 15,445 | 4,203,218 | 4.2 M to 4.2 M (-0.01 %) |
| Apr 03 2019 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 35.79 | 491 | 17,573 | 4,203,695 | 4.2 M to 4.2 M (-0.01 %) |
| Mar 22 2019 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 38.62 | 496 | 19,156 | 4,204,186 | 4.2 M to 4.2 M (-0.01 %) |
| Mar 22 2019 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 38.62 | 496 | 19,156 | 4,204,186 | 4.2 M to 4.2 M (-0.01 %) |
| Feb 08 2019 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Option Exercise | A | 27.76 | 62,634 | 1,738,720 | 62,634 | |
| Feb 08 2019 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Grant | A | 0.00 | 39,215 | 0 | 4,204,682 | 4.2 M to 4.2 M (+0.94 %) |
| Feb 06 2019 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 27.80 | 345 | 9,591 | 4,165,467 | 4.2 M to 4.2 M (-0.01 %) |
| Jan 24 2019 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 24.74 | 8,825 | 218,334 | 4,165,812 | 4.2 M to 4.2 M (-0.21 %) |
| Jan 04 2019 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 20.67 | 4,424 | 91,444 | 4,174,637 | 4.2 M to 4.2 M (-0.11 %) |
| Jul 24 2018 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 52.00 | 12,520 | 651,020 | 4,179,061 | 4.2 M to 4.2 M (-0.30 %) |
| Feb 13 2018 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Option Exercise | A | 60.85 | 56,940 | 3,464,799 | 56,940 | |
| Feb 13 2018 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Grant | A | 0.00 | 35,650 | 0 | 4,191,581 | 4.2 M to 4.2 M (+0.86 %) |
| Jan 24 2018 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 92.75 | 10,692 | 991,683 | 4,155,931 | 4.2 M to 4.2 M (-0.26 %) |
| Jul 24 2017 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 95.60 | 4,000 | 382,400 | 4,166,623 | 4.2 M to 4.2 M (-0.10 %) |
| Jul 24 2017 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 94.34 | 9,175 | 865,605 | 4,170,623 | 4.2 M to 4.2 M (-0.22 %) |
| Feb 21 2017 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Option Exercise | A | 37.35 | 70,000 | 2,614,500 | 70,000 | |
| Jan 24 2017 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Sell | S | 33.24 | 10,202 | 339,064 | 4,179,798 | 4.2 M to 4.2 M (-0.24 %) |
| Oct 14 2016 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Grant | A | 0.00 | 150,000 | 0 | 4,190,000 | 4 M to 4.2 M (+3.71 %) |
| Jun 02 2016 | RDUS | Radius Health, Inc ... | AUERBACH ALAN H | Director | Option Exercise | A | 37.07 | 27,500 | 1,019,425 | 27,500 | |
| May 27 2016 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Option Exercise | A | 35.61 | 66,667 | 2,374,012 | 66,667 | |
| Feb 12 2016 | RDUS | Radius Health, Inc ... | AUERBACH ALAN H | Director | Option Exercise | A | 29.89 | 27,500 | 821,975 | 27,500 | |
| Oct 09 2015 | PBYI | PUMA BIOTECHNOLOGY ... | AUERBACH ALAN H | PRESIDENT AND CEO | Option Exercise | A | 76.54 | 150,000 | 11,481,000 | 150,000 | |
| May 26 2015 | RDUS | Radius Health, Inc ... | AUERBACH ALAN H | Director | Option Exercise | A | 36.74 | 15,000 | 551,100 | 15,000 | |
| Jul 07 2009 | CGRB | Cougar Biotechnolo ... | AUERBACH ALAN H | President and CEO | Option Exercise | D | 28.43 | 150,000 | 4,264,500 | 0 | |
| Jul 07 2009 | CGRB | Cougar Biotechnolo ... | AUERBACH ALAN H | President and CEO | Option Exercise | D | 24.50 | 100,000 | 2,450,000 | 0 | |
| Jul 07 2009 | CGRB | Cougar Biotechnolo ... | AUERBACH ALAN H | President and CEO | Option Exercise | D | 4.50 | 161,326 | 725,967 | 0 | |
| Jul 07 2009 | CGRB | Cougar Biotechnolo ... | AUERBACH ALAN H | President and CEO | Option Exercise | D | 4.82 | 90,650 | 436,933 | 0 | |
| Jul 07 2009 | CGRB | Cougar Biotechnolo ... | AUERBACH ALAN H | President and CEO | Option Exercise | D | 0.39 | 288,083 | 112,352 | 0 | |
| Jul 07 2009 | CGRB | Cougar Biotechnolo ... | AUERBACH ALAN H | President and CEO | Option Exercise | D | 4.50 | 336,139 | 1,512,626 | 0 | |
| Jul 07 2009 | CGRB | Cougar Biotechnolo ... | AUERBACH ALAN H | President and CEO | Sell | U | 43.00 | 288,083 | 12,387,569 | 0 | 288.1 K to 0 (-100.00 %) |
| Jun 05 2008 | CGRB | Cougar Biotechnolo ... | AUERBACH ALAN H | President and CEO | Option Exercise | A | 28.43 | 150,000 | 4,264,500 | 150,000 | |
| Jun 15 2007 | CGRB | Cougar Biotechnolo ... | AUERBACH ALAN H | President and CEO | Option Exercise | A | 24.50 | 100,000 | 2,450,000 | 100,000 | |
| Oct 02 2006 | CGRB | Cougar Biotechnolo ... | AUERBACH ALAN H | President and CEO | Option Exercise | A | 4.50 | 336,139 | 1,512,626 | 336,139 |
Page: 1